Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer
Status:
Recruiting
Trial end date:
2026-11-30
Target enrollment:
Participant gender:
Summary
This study aims to elucidate the effects of neoadjuvant Tislelizumab combined with
chemotherapy in locally advanced Microsatellite Stable (MSS) colon cancer.
Phase:
Phase 2
Details
Lead Sponsor:
First Affiliated Hospital of Guangxi Medical University